Schenkein David P
SEC CIK 1578200 · EDGAR
BoughtSold
Most active insiders at DNLI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watts Ryan J. | Pres, CEO, Dir | — | $580.8K |
| 2 | Schuth Alexander O. | COFO, Sec | — | $420.6K |
| 3 | Thornberry Nancy | Dir | — | $261.9K |
| 4 | Chin Peter Scott | Chief Medical Off | — | $36.9K |
| 5 | Van Hauwermeiren Timothy | Dir | — | — |
| 6 | Cook Jennifer E. | Dir | — | — |
| 7 | Krognes Steve E. | Dir | — | — |
| 8 | Schenkein David P | Dir | — | — |
| 9 | Klein Peter S | Dir | — | — |
| 10 | BAKER BROS. ADVISORS LP | Dir | — | — |
Transactions 34
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-05 16:45 | 2026-06-03 | DNLI | Denali Therapeutics Inc. | Schenkein David P | Dir | A - Grant | $0.00 | +6,408 | 21.7K | +42% | $0 |
| D | 2026-01-06 | 2026-01-02 | REGN | Regeneron Pharmaceuticals | Schenkein David P | Dir | A - Grant | $0.00 | +155 | 603 | +35% | $0 |
| D | 2025-06-05 | 2025-06-03 | DNLI | Denali Therapeutics Inc. | Schenkein David P | Dir | A - Grant | $0.00 | +6,037 | 15.3K | +65% | $0 |
| D | 2025-01-06 | 2025-01-02 | REGN | Regeneron Pharmaceuticals | Schenkein David P | Dir | A - Grant | $0.00 | +166 | 448 | +59% | $0 |
| D | 2024-11-13 | 2024-11-11 | DNLI | Denali Therapeutics Inc. | Schenkein David P | Dir | M - OptEx | $18.00 | +47.2K | 68.7K | +219% | +$849.0K |
| DM | 2024-11-13 | 2024-11-11 | DNLI | Denali Therapeutics Inc. | Schenkein David P | Dir | S - Sale+OE | $32.51 | -59.4K | 9,220 | -87% | -$1.93M |
| D | 2024-06-17 | 2024-06-13 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | M - OptEx | $0.00 | +3,388 | 126.2K | +3% | $0 |
| D | 2024-06-04 | 2024-05-31 | DNLI | Denali Therapeutics Inc. | Schenkein David P | Dir | A - Grant | $0.00 | +5,967 | 21.5K | +38% | $0 |
| DM | 2024-02-29 | 2024-02-27 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | S - Sale+OE | $34.67 | -69.3K | 122.9K | -36% | -$2.40M |
| DM | 2024-02-29 | 2024-02-27 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | M - OptEx | $31.64 | +69.3K | 180.3K | +62% | +$2.19M |
| DM | 2024-02-27 | 2024-02-23+ | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | M - OptEx | $31.64 | +68.1K | 170.6K | +67% | +$2.16M |
| DM | 2024-02-27 | 2024-02-23+ | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | S - Sale+OE | $33.09 | -68.1K | 122.9K | -36% | -$2.25M |
| D | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | Schenkein David P | Dir | A - Grant | $0.00 | +42 | 282 | +18% | $0 |
| D | 2023-09-12 | 2023-09-08 | REGN | Regeneron Pharmaceuticals | Schenkein David P | Dir | A - Grant | $0.00 | +240 | 240 | New | $0 |
| D | 2023-06-23 | 2023-06-21 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | M - OptEx | $0.00 | +4,975 | 122.9K | +4% | $0 |
| D | 2023-06-05 | 2023-06-01 | DNLI | Denali Therapeutics Inc. | Schenkein David P | Dir | A - Grant | $0.00 | +4,216 | 15.5K | +37% | $0 |
| D | 2023-04-05 | 2023-04-03 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | S - Sale+OE | $22.85 | -16.4K | 117.9K | -12% | -$373.9K |
| D | 2023-04-05 | 2023-04-03 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | M - OptEx | $9.05 | +16.4K | 134.2K | +14% | +$148.1K |
| D | 2023-03-29 | 2023-03-27 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | M - OptEx | $9.05 | +20.0K | 137.9K | +17% | +$181.0K |
| D | 2023-03-29 | 2023-03-27 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | S - Sale+OE | $22.15 | -20.0K | 117.9K | -15% | -$443.0K |
| DM | 2023-03-15 | 2023-03-13 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | S - Sale+OE | $22.49 | -20.0K | 119.5K | -14% | -$449.8K |
| D | 2023-03-15 | 2023-03-13 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | M - OptEx | $9.05 | +20.0K | 137.9K | +17% | +$181.0K |
| D | 2023-03-01 | 2023-02-27 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | S - Sale+OE | $25.37 | -20.0K | 117.9K | -15% | -$507.4K |
| D | 2023-03-01 | 2023-02-27 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | M - OptEx | $9.05 | +20.0K | 137.9K | +17% | +$181.0K |
| D | 2023-02-15 | 2023-02-13 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | M - OptEx | $9.05 | +20.0K | 137.9K | +17% | +$181.0K |
| D | 2023-02-15 | 2023-02-13 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | S - Sale+OE | $28.62 | -20.0K | 117.9K | -15% | -$572.4K |
| D | 2023-02-01 | 2023-01-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | M - OptEx | $9.05 | +20.0K | 137.9K | +17% | +$181.0K |
| DM | 2023-02-01 | 2023-01-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | S - Sale+OE | $29.33 | -20.0K | 117.9K | -15% | -$586.6K |
| D | 2023-01-19 | 2023-01-17 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | M - OptEx | $9.05 | +20.0K | 137.9K | +17% | +$181.0K |
| DM | 2023-01-19 | 2023-01-17 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | S - Sale+OE | $28.85 | -20.0K | 118.9K | -14% | -$577.1K |
| D | 2022-06-06 | 2022-06-02 | DNLI | Denali Therapeutics Inc. | Schenkein David P | Dir | A - Grant | $0.00 | +5,986 | 11.3K | +112% | $0 |
| D | 2022-05-24 | 2022-05-20 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | M - OptEx | $0.00 | +1,585 | 117.9K | +1% | $0 |
| D | 2022-02-23 | 2022-02-22 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | F - Tax | $29.08 | -758 | 116.3K | -0.6% | -$22.0K |
| D | 2022-02-23 | 2022-02-22 | AGIO | AGIOS PHARMACEUTICALS, INC. | Schenkein David P | Dir | M - OptEx | $0.00 | +2,775 | 117.1K | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations